Acsana — from promise to practice
The barrier to impact is not usually the technology. It is adoption, evidence, financing, trust, and fit with real health systems.
I bring senior medical judgement to medtech companies and the investors who back them, in markets across the world.
Dr Paul Rutter
I am a physician who has led major multi-country health programs at WHO and UNICEF, and held senior roles at medtech startups with global reach.
Through Acsana, I bring senior medical judgement to medtech companies and the investors who back them, helping products move from promise to practice in markets across the world.
My knowledge and experience span the full medtech triad:
Fractional Chief Medical Officer
Senior medical and health-system judgement for companies that do not, or not yet, need a full-time CMO.
Global Markets Advisory
Specialist input for larger companies expanding their global reach and impact.
Due Diligence
For investors and funders: a clear-eyed read on whether a medtech product has a credible pathway to adoption and revenue.